Background With the easing of COVID-19 non-pharmaceutical interventions, the resurgence
of both influenza and respiratory syncytial virus (RSV) was observed in several countries …

Since the 20 th century, humans have lived through five pandemics caused by influenza A
viruses (IAVs)(H1N1/1918, H2N2/1957, H3N2/1968, and H1N1/2009) and the coronavirus …

The lifting of non-pharmaceutical measures preventing transmission of SARS-CoV-2 (and
other viruses, including influenza viruses) raises concerns about healthcare resources and …

As SARS-CoV-2 and influenza viruses co-circulate, co-infections with these viruses
generate an increasing concern to public health. To evaluate the prevalence and clinical …

Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic in Wuhan,
China, in December 2019, there has been a significant focus placed on its transmission …

The molecular detection of multiple respiratory viruses provides evidence for the rational use
of drugs and effective health management. Herein, we developed and tested the clinical …

Viral infection in respiratory tract usually leads to cell death, impairing respiratory function to
cause severe disease. However, the diversity of clinical manifestations of SARS-CoV-2 …

Respiratory syncytial virus infection in the modern era : Current Opinion in Infectious
Diseases Respiratory syncytial virus infection in the modern era : Current Opinion in …

Background The US confronted a “triple-demic” of influenza, respiratory syncytial virus
(RSV), and COVID-19 in the winter of 2022, leading to increased respiratory infections and a …

As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …